Advertisement

Topics

Latest "Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in Children" News Stories - Page: 20

08:33 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in Children" found in our extensive news archives from over 250 global news sources.

More Information about Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in Children on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in Children for you to read. Along with our medical data and news we also list Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in Children Clinical Trials, which are updated daily. BioPortfolio also has a large database of Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in Children Companies for you to search.

Showing "Study Anti reflux Medication Potential Treatment Glue Children" News Articles 476–500 of 44,000+

Tuesday 19th March 2019

Agility in Rare Disease and Oncology Clinical Trials – Data Management, New Webinar Hosted by Xtalks

Modular and adaptive clinical trials are rapidly expanding the ability of researchers to modify clinical trials based on emerging data, i.e. to make better decisions based on positive clinical response. This is a flexible process which provides data on the smallest number of patients so that drug developers can pre-plan alternative paths for the trial during the design stage. TORONTO (PRWEB) March...


FDA Approves Tecentriq + Chemotherapy for Treatment of Small Cell Lung Cancer

IMPower133 clinical trial leads to Tecentriq being first new approved initial treatment for SCLC in years.

Getting to the Core of the Apple Heart Study

The co-principal investigator of a study that assessed the ability of an Apple Watch app to detect atrial fibrillation discusses the findings with John Mandrola, MD. theheart.org on Medscape


Millendo Therapeutics Initiates Pivotal Phase 2b/3 Clinical Study of Livoletide for the Treatment of Prader-Willi Syndrome

Top-line Phase 2b results are expected in 1H 2020 and may support an NDA submission for livoletide Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company developing novel treatments for orphan endocrine dise

Endospan Secures CE Mark Approval for Branched Endovascular Repair of the Aortic Arch with Its NEXUS™ Aortic Arch Repair System

With regulatory approval in Europe of its innovative NEXUS™ Stent Graft System, Endospan intends to transform the treatment of life-threatening Aortic Arch Disease from a high-risk open surgery into a minimally invasive aortic arch repair for both aneurysms and dissections. Endospan, a pioneer in off-the-shelf, minimally invasive endovascular repair ...

Omeros Corporation Announces Upcoming Educational Event at the Annual Meeting of the European Society of Blood and Marrow Transplantation

--Session Will Focus on Diagnosis of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy-- Omeros Corporation (Nasdaq: OMER) today announced an upcoming educational event at the 2019 Annual Meeting of the European Society of Blood and Marrow Transplantation to be held in Frankfurt, Germany on March 24-27, 2019. Sponsored by Om...

Cabozantinib Active Across Rarer, Heterogeneous, Non-Clear Cell RCCs (CME/CE)

(MedPage Today) -- A retrospective, real-world study

Urovant says experimental drug vibegron hits main goals of late-stage overactive bladder study https://www.firstwordpharma.com/node/1630446  $UROV

Urovant says experimental drug vibegron hits main goals of late-stage overactive bladder study https://www.firstwordpharma.com/node/1630446  $UROV

Cybersecurity breach pay: CEOs get pay rises following an attack while shareholders lose out

A study into cybersecurity breach pay has found that in the aftermath of a cyberattack or other similar security breach,...Read More... The post Cybersecurity breach pay: CEOs get pay rises following an attack while shareholders lose out appeared first on Pharmaceutical Technology.

Minn. House Passes Bill That Would Raise Registration Fees For Drugmakers With The Money Going Toward Opioid Crisis

The fees would bring in $20 million a year and would be used for education, intervention, treatment and recovery strategies. Meanwhile, a report finds that opioid and suicide deaths in the state are still on the rise.

Schools Tap Students To Help Fight Vaping Epidemic So That Message Is Coming From A Friend Instead Of An Adult

"It's more effective to have students themselves who live in those areas, who go to those schools, who are part of the community to share their voice, share their story and to share why it's harmful," said Sonia Gutierrez, a supervisor with the Santa Clara County Office of Education in California. In other news on children's health: professional hair removal for pre-teens and fighting food allergi...

Contraception App Claims It’s 99 Percent Effective, But Questions About How To Even Test That Rate Remain Unanswered

The app gives users a window of about 11 to 13 days during which they should use a condom or another birth control method to prevent pregnancy. Although a new study shows that it can be effective if used correctly, that data assumes the people who don't respond aren't pregnant, which is an underlying obstacle to proving efficacy on apps like these. In other public health news: the microbiome, brok...

When Drug Costs Get Too High, Patients Are Skipping Doses Or Just Not Taking Medication

Experts are worried this behavior could be extremely dangerous for the patients. “We have lots of treatments where if you don’t take them exactly as prescribed, you might be doing more harm than good,” said Stacie Dusetzina, a health policy researcher at Vanderbilt University. Other ways patients are trying to control costs are by asking for cheaper drugs from doctors or seeking out alternat...

Apple Watch shows promise in heart study, but doctors sceptical

Study important for Apple's ambitions in healthcare

New data for Medtronic, Edwards TAVR valves may bring broader indication

Study data show use of Edwards Lifesciences' Sapien 3 transcatheter aortic valve replacement system and Medtronic's Evolut R, -More- 

Tecentriq Approved for Small Cell Lung Cancer

TUESDAY, March 19, 2019 -- Tecentriq (atezolizumab) has been approved by the U.S. Food and Drug Administration to treat adults with extensive-stage small cell lung cancer (ES-SCLC). The drug has been approved as a first-line treatment for the...

Favorable Outcomes Seen in Long Term for ALLR3 Trial

TUESDAY, March 19, 2019 -- For children with B-cell precursor acute lymphoblastic leukemia with late bone marrow relapse, risk stratification by minimal residual disease seems to be an effective strategy for treatment, according to a study recently...

Light Physical Activity Tied to Lower CHD, CVD Risk in Women

TUESDAY, March 19, 2019 -- Light physical activity (PA) is associated with reductions in coronary heart disease (CHD) and cardiovascular disease (CVD) among older women, according to a study published online March 15 in JAMA Network Open. Andrea Z....

Novel Checklist Can Distinguish Anthrax Exposure From Other Illnesses

TUESDAY, March 19, 2019 -- A newly developed checklist can rapidly identify anthrax cases after a suspected mass exposure, according to a study published online March 19 in the Annals of Internal Medicine. Nathaniel Hupert, M.D., M.P.H., from the...

Female Emergency Physicians Paid Less Than Males

TUESDAY, March 19, 2019 -- A gender-based salary gap persists among academic emergency medicine physicians, according to a study published in the March issue of Academic Emergency Medicine. Jennifer L. Wiler, M.D., from the University of Colorado in...

ACC: Icosapent Ethyl Beneficial for Statin-Treated Patients

TUESDAY, March 19, 2019 -- For statin-treated patients with elevated triglycerides and established cardiovascular disease or diabetes, icosapent ethyl is associated with a reduced rate of total primary end point events, according to a study...

Limitations in Single-Cell Analysis Must Be Addressed with Innovation

Single-cell analysis is transforming how we understand disease, with a growing recognition that cell populations harbor far more heterogeneity than expected—and that bulk population analysis is inadequate for fully characterizing biological complexity. Advances in single-cell genomics, transcriptomics, and proteomics will enable significant improvements in how we approach the clinical research, ...

Bluetooth Technology Enables Insulin Adherence Monitoring

TUESDAY, March 19, 2019 -- Adherence to timing and dosing of insulin injections can be objectively measured using Bluetooth-enabled pen caps, according to a study published online March 12 in Diabetes Care. Medha N. Munshi, M.D., from the Joslin...

Neighborhood-Level Socioeconomics Tied to MS Disability Progression

TUESDAY, March 19, 2019 -- Lower neighborhood-level socioeconomic status (SES) is associated with a higher risk for disability progression in patients with multiple sclerosis (MS), according to a study recently published in Neurology. Katharine E....

Testosterone Replacement Slows Prostate Cancer Recurrence

TUESDAY, March 19, 2019 -- For patients with localized prostate cancer, testosterone replacement therapy (TRT) slows recurrence, according to a study presented at the annual meeting of the European Association of Urology, held from March 15 to 19 in...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks